Biotech · Private company · Cambridge, MA, US
Astrocyte Pharmaceuticals, Inc.
Track this companyFree. Adds Astrocyte Pharmaceuticals, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards3
- Preclinical efficacy of AST-004 as a treatment for substance use disorderFiscal year 2026 · $399.7KNIH RePORTER 1R41DA064479-01 · fetched Nov 12, 2026
- Preclinical Efficacy and Safety Evaluation of Oral AST-004 for Moderate Traumatic Brain Injury (TBI)Fiscal year 2026 · $1.5MNIH RePORTER 5R44NS137896-02 · fetched Nov 12, 2026
- Preclinical Efficacy and Safety Evaluation of Oral AST-004 for Moderate Traumatic Brain Injury (TBI)Fiscal year 2025 · $1.5MNIH RePORTER 1R44NS137896-01A1 · fetched Nov 12, 2026